Pacifico Biolabs Raises €7M to Turn Brewery Infrastructure into Protein Production

Pacifico Biolabs, a mycelium fermentation protein company, led by Zac Austin, Washington Logroño, and the team, has raised €7 million in a Series A funding round backed by Stray Dog Capital, TGFS, Sprout & About Ventures, Simon Capital, FoodLabs, and a regional brewery partner.

Pacifico Biolabs develops protein ingredients using mycelium fermentation technology, leveraging standard brewery fermentation tanks instead of custom-built bioreactors to reduce production costs and utilize existing industrial infrastructure.

The strategy aligns with growing underutilized brewery capacity across Europe as beer and alcohol consumption declines, allowing the company to scale production more efficiently by repurposing existing fermentation facilities rather than constructing new ones.

Pacifico Biolabs aims to reduce Europe’s reliance on imported feed protein by producing a domestically manufactured alternative using mycelium fermentation and existing brewery infrastructure, improving supply chain resilience and proximity to consumption.

By repurposing fermentation capacity, the company also targets lower production costs and closer parity with conventional meat. The funding will support scaling in Saxony, Germany, team expansion, and commercial launches across the DACH and Nordic regions ahead of planned retail rollout by late 2026.